Within a the latest study, we documented the identification as well as the characterization of a different atypical opioid receptor with unique damaging regulatory Qualities in the direction of opioid peptides.1 Our effects confirmed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is usuall